Clinical Trial Update: Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating targeting monoaminergic neuronal networks in patients with carbon monoxide-induced parkinsonism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbon Monoxide-induced Parkinsonism

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Carbon Monoxide-induced Parkinsonism | Phase 3 | Status: UNKNOWN